Streetbeat News

Regulatory

ZVSA

ZyVersa Therapeutics has announced a publication in Clinical Immunology that demonstrates a link between renal NLRP3 inflammasome activation and Lupus Nephritis disease activity. The company is developing Inflammasome ASC Inhibitor IC 100, which can inhibit up to 12 different inflammasomes, including NLRP3 inflammasomes.

Portfolio Pulse from Bill Haddad

June 28, 2023 | 11:39 am

OPK

PFE

The FDA has approved the NGENLA (somatrogon-ghla) treatment for pediatric growth hormone deficiency, a partnership product of Opko Health and Pfizer. This has led to a rise in Opko Health's shares.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:38 am

AVXL

Anavex Life Sciences has announced long-term clinical study results for ANAVEX 2-73-RS-001, showing disease modifying effects in Rett Syndrome. The results could potentially lead to a new treatment for the disease.

Portfolio Pulse from Bill Haddad

June 28, 2023 | 11:37 am

ZLAB

Zai Lab has announced that China's National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for Repotrectinib for patients with ROS1-Positive NSCLC. This is a significant step for Zai Lab in their efforts to bring this drug to market.

Portfolio Pulse from Bill Haddad

June 28, 2023 | 11:34 am

AMD

AMD shares are trading lower following reports of the U.S. planning to revise its export controls on AI chips, which could limit China's access to advanced technologies with military applications.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:31 am

AMD

NVDA

QQQ

SPY

Stock futures indicate a mixed opening on Wall Street, with traders anticipating comments from Federal Reserve Chair Jerome Powell and the release of the Fed’s bank stress test results. The technology sector, particularly the chip industry, may face pressure amid reports of a U.S. ban on Chinese chips. Carson Group analyst Ryan Detrick remains optimistic about the near-term market outlook, advising to buy weakness. In premarket trading, the SPDR S&P 500 ETF Trust (SPY) fell 0.17% and the Invesco QQQ ETF (QQQ) slipped 0.36%. Nvidia Corp. (NVDA) and Advanced Micro Devices, Inc. (AMD) fell over 4% and 3%, respectively, following reports of the China chip ban.

Portfolio Pulse from Shanthi Rexaline

June 28, 2023 | 11:27 am

TOVX

Theriva Biologics has announced that the FDA has granted orphan drug designation to VCN-01 for pancreatic cancer, leading to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:24 am

CGC

Canopy Growth Corporation announced that KPMG has resigned as the company's independent registered public accounting firm.

Portfolio Pulse from Charles Gross

June 28, 2023 | 11:20 am

BTC-USD

Robert F. Kennedy Jr.'s bid for the Democratic nomination is seen as a potential advantage for Republicans in their efforts against President Biden. Kennedy's rise in the polls and his appeal to a faction of the right that questions vaccine mandates have intrigued Republicans. His support for Bitcoin and criticism of Biden's crypto tax proposal have also garnered attention.

Portfolio Pulse from Benzinga Newsbot

June 28, 2023 | 11:17 am

SYBX

The World Health Organization's International Nonproprietary Names Expert Committee has chosen Labafenogene Marselecobac as the nonproprietary name for Synlogic's investigational drug for Phenylketonuria, previously known as SYNB1934.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:17 am